Ignite Creation Date:
2024-05-05 @ 9:53 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004408
Status:
COMPLETED
Last Update Posted:
2012-03-06
First Post:
1999-10-18
Brief Title:
Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease
Sponsor:
Mast Therapeutics Inc
Organization:
Mast Therapeutics Inc
Organization Data
Organization:
Mast Therapeutics Inc
Class:
INDUSTRY
Study ID:
19913296
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mast Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| CytRx | INDUSTRY |